Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1136-1144

  Cho, Jae Ho ^a   Lee, Seung Woo ^a   Sung, Young Chul ^a  

^a Department of Chemistry   (South Korea)

Author keywords

Bicistronic plasmid; DNA immunization; Hepatitis C virus; Nonstructural protein

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CISTRON; CONTROLLED STUDY; DRUG EFFECT; GENE TARGETING; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPACIVIRUS; HEPATITIS C ANTIBODIES; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; RATS; RATS, INBRED BUF; VACCINATION; VACCINES, DNA; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0344097496     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00333-8     Document Type: Article

References (64)

1. Alter H.J., Purcell R., Shih J., Melpolder J., Houghton M., Choo Q.L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 321:1989;1494-1500.
2. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
3. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E., Meeks E.L., Beach M.J. The natural history of community-acquired hepatitis C in the United States: the sentinel counties chronic non-A, non-B hepatitis study team. N Engl J Med. 327:1992;1899-1905.
4. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kituchi S., Koi S., Onji M., Ohta Y., Choo Q.L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.
5. Selby M.J., Choo Q.L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol. 74:1993;1103-1113.
6. Grakoui A., Wychowski C., Lin C., Feinstone S.M., Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 67:1993;1385-1395.
7. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi Y., Kato N., Kimura K., Shimotohno K. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA. 90:1993;10773-10777.
8. Battegay M., Fidkes J., Di Bisceglie A.M., Wentworth P.A., Sette A., Celis E., Ching W.M., Grakoui A., Rice C.M., Kurokohchi K., Berzofsky J.A., Hoofnagle J.H., Feinstone S.M., Akatsuka T. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2462-2470.
9. Erickson A.L., Houghton M., Choo Q.L., Weiner A.J., Ralston R., Muchmore E., Walker C.M. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 151:1993;4189-4199.
10. Sallberg M., Zhang Z.X., Chen M., Jin L., Birkett A., Peterson D.L., Milich D.R. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus nonstructural 3 protein. J Gen Virol. 77:1996;2721-2728.
11. Zhang Z.X., Chen M., Hultgren C., Birkett A., Milich D.R., Sallberg M. Immune responses to the hepatitis C virus NS4A protein are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex. J Gen Virol. 78:1997;2735-2746.
12. Cerino A., Mondelli M.U. Identification of an immunodominant B-cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. J Immunol. 147:1991;2692-2696.
13. Cerny A., McHutchison J.G., Pasquinelli C., Brown M.E., Brothers M.A., Grabscheid B., Fowler P., Houghton M., Chisari F.V. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest. 95:1995;521-530.
14. Diepolder H.M., Gerlach J.T., Zachoval R., Hoffmann R.M., Jung M.C., Wierenga E.A., Scholz S., Santantonio T., Houghton M., Southwood S., Sette A., Pape G.R. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol. 71:1997;6011-6019.
15. Hwang L.H., Yang P.M., Lai M.Y., Chiang B.L., Kao J.H., Wang J.T., Lee S.Y., Chian H.M., Chi W.K., Chu Y.D., Chen P.J., Chen D.S. Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein. J Infect Dis. 174:1996;173-176.
16. Khudyakov E., Khudyakova N.S., Jue D.L., Lambert S.B., Fang S., Fields H.A. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology. 206:1995;666-672.
17. Mondelli M.U., Cerino A., Boender P., Oudshoorn P., Middeldorp J., Fipaldini C., La Monica N., Habets W. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol. 68:1994;4829-4836.
18. Shirai M., Akatsuka T., Pendleton C.D., Houghten R., Wychowski C., Mihalik K., Feinstone S.M., Berzofsky J.A. Induction of cytotoxic T-cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol. 66:1992;4098-4106.
19. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., Eichenlaub D., Pape G.R. Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
20. Diepolder H.M., Zachoval R., Hoffmann R.M., Jung M.C., Gerlach T., Pape G.R. The role of hepatitis C virus specific CD4+ T-lymphocytes in acute and chronic hepatitis C. J Mol Med. 74:1996;583-588.
21. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M.G., Fiaccadori F. T-cell responses to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
22. Irwin M.J., Laube L.S., Lee V., Austin M., Chada S., Anderson C.G., Townsend K., Jolly D.J., Warner J.F. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J Virol. 68:1994;5036-5044.
23. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
24. Cox G.J., Zamb T.J., Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 67:1993;5664-5667.
25. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc Natl Acad Sci USA. 90:1993;11478-11482.
26. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
27. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., Dewitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
28. Geissler M., Gesien A., Wands J.R. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J Immunol. 159:1997;5107-5113.
29. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 158:1997;4591-4601.
30. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol. 159:1997;3638-3647.
31. Sin J.I., Sung J.H., Suh Y.S., Lee A.H., Chung J.H., Sung Y.C. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte macrophage colony stimulating factor gene. Vaccine. 15:1997;1827-1833.
32. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol. 71:1997;169-178.
33. Hahm B.S., Han D.S., Back S.H., Song O.K., Cho M.J., Kim C.J., Shimotohno K., Jang S.K. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol. 69:1995;2534-2539.
34. Lee A.H., Suh Y.S., Sung J.H., Yang S.H., Sung Y.C. Comparison of various expression plasmids for the induction of immune response by DNA immunization. Mol Cells. 7:1997;495-501.
35. Moss B., Elroy-Stein O., Mizukami T., Alexander W.A., Fuerst T.R. Product review. New mammalian expression vectors. Nature. 348:1990;91-92.
36. Lee K.J., Suh Y.A., Cho Y.G., Cho Y.S., Ha J.W., Chung K.H., Hwang J.W., Yun Y.D., Lee D.S., Kim C.M., Sung Y.C. Hepatitis C virus E2 protein purified from mammalian cells is frequently recognized by E2-specific antibodies in patient sera. J Biol Chem. 272:1997;30040-30046.
37. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q.L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol. 67:1993;6753-6761.
38. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988. p. 561-91.
39. Henthorn P., Zervos P., Raducha M., Harris H., Kadesch T. Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. Proc Natl Acad Sci USA. 85:1988;6342-6346.
40. Cho Y.G., Yoon J.W., Jang K.L., Kim C.M., Sung Y.C. Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Mol Cells. 3:1993;195-202.
41. Wells D.J. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 332:1993;179-182.
42. Lefkovits I. Immunology methods manual: the comprehensive sourcebook of techniques, vol. 2. Academic Press, Harcourt Brace and Company, Publishers, 1997. p. 1068.
43. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology, vol. 1. National Institutes of Health, Wiley Interscience, 1991. p. 3.1.5.
44. Lin C., Pragai B.M., Grakoui A., Xu J., Rice C.M. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol. 68:1994;8147-8157.
45. Shoji I, Sato M, Suzuki T, Matsuura Y, Miyamura T. Further cleavage of HCV NS3 protein. 5th International meeting on hepatitis C virus and related viruses, Molecular virology and pathogenesis, Venezia, Italy, 1998. p. C-9.
46. Chiba Y., Dzierba J.L., Morag A., Ogra P.L. Cell-mediated immune response to mumps virus infection in man. J Immunol. 116:1976;12-15.
47. Bright R.K., Shearer M.H., Kennedy R.C. Nucleic acid vaccination against virally induced tumors. Ann NY Acad Sci. 772:1995;241-251.
48. Sarzotti M., Dean T.A., Remington M.P., Ly C.D., Furth P.A., Robbins D.S. Induction of cytotoxic T-cell responses in newborn mice by DNA immunization. Vaccine. 15:1997;795-797.
49. Suradhat S., Yoo D., Babiuk L.A., Griebel P., Baca-Estrada M.E. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice. Viral Immunol. 10:1997;117-127.
50. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol. 154:1995;4010-4017.
51. Bright R.K., Beames B., Shearer M.H., Kennedy R.C. Protection against a lethal tumor challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Cancer Res. 56:1996;1126-1130.
52. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
53. Lee SW, Cho JH, Sung YC. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte macrophage colony stimulating factor gene. J Virol 1998;72:8430-6.
54. Robinson H.L., Torres C.A. DNA vaccines. Semin Immunol. 9:1997;271.
55. Robinson H.L. Nucleic acid vaccines: an overview. Vaccine. 15:1997;785-787.
56. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol. 158:1997;4529-4532.
57. Svanholm C., Lowenadler B., Wigzell H. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by coinjection with a GM-CSF expression vector. Scand J Immunol. 46:1997;298-303.
58. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
59. Botarelli P., Brunetto M.R., Minutello M.A., Calvo P., Unutmaz D., Weiner A.J., Choo Q.L., Shuster J.R., Kuo G., Bonino F., Houghton M., Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
60. Kita H., Moriyama T., Kaneko T., Hiroishi K., Harase I., Miura H., Nakamura I., Inamori H., Kodama T., Ohnishi S., Yazaki Y., Imawari M. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro. J Med Virol. 45:1995;386-391.
61. Lechmann M., Ihlenfeldt H.G., Braunschweiger I., Giers G., Jung G., Matz B., Kaiser R., Sauerbruch T., Spengler U. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology. 24:1996;790-795.
62. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., Rumi M.G., Houghton F., Fiaccadori F., Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 98:1996;706-714.
63. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., Walker B.D. Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia. Science. 278:1997;1447-1450.
64. Battegay M., Moskophidis D., Rahemtulla A., Hengartner H., Mak T.W., Zinkernagel R.M. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol. 68:1994;4700-4704.